Marine bacterial sources of bioactive compounds

Area of Science:

• Marine microbiology
• Natural product chemistry
• Pharmacology

Background:

• Marine bacteria are a rich source of novel compounds with diverse pharmacological activities.
• Many marine-derived compounds are progressing through preclinical and clinical development.
• Marine actinomycetes and cyanobacteria are particularly promising, yet underexploited, sources of bioactive metabolites.

Purpose of the Study:

• To highlight the significance of marine bacteria as a source of pharmacologically active compounds.
• To emphasize the growing interest and technological advancements in discovering marine-derived antiviral agents.
• To underscore the potential of marine actinomycetes and cyanobacteria for novel secondary metabolite discovery.

Main Methods:

• Isolation and characterization of novel compounds from marine bacteria.
• Pharmacological testing of isolated compounds for various bioactivities.
• Advancements in marine culture and extraction technologies.

Main Results:

• Thousands of novel compounds have been isolated and tested, with many showing commercial availability.
• Numerous marine-derived compounds are currently under preclinical and clinical investigation.
• Marine actinomycetes and cyanobacteria have been identified as prolific sources of unique secondary metabolites.

Conclusions:

• Marine environments represent a crucial and promising frontier for drug discovery.
• Technological progress is accelerating the identification of marine-derived compounds for therapeutic applications.
• Marine actinomycetes and cyanobacteria offer significant untapped potential for discovering new medicines.